Neuburgh Advisers’s CVS Health CVS Stock Holding History

Neuburgh Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.35M	Sell	21,392 -2,320	-10%	-$137K	0.04%	279
2019 Q2	$1.29M	Sell	23,712 -11,440	-33%	-$616K	0.04%	290
2019 Q1	$1.9M	Sell	35,152 -20,096	-36%	-$1.24M	0.06%	210
2018 Q4	$3.62M	Buy	55,248 +10,512	+23%	+$785K	0.14%	137
2018 Q3	$3.52M	Sell	44,736 -15,472	-26%	-$1.11M	0.11%	164
2018 Q2	$3.88M	Sell	60,208 -16,592	-22%	-$1.09M	0.13%	150
2018 Q1	$4.78M	Sell	76,800 -44,160	-37%	-$3.17M	0.17%	122
2017 Q4	$8.77M	Sell	120,960 -2,896	-2%	-$211K	0.31%	71
2017 Q3	$10.1M	Buy	123,856 +35,472	+40%	+$2.81M	0.37%	63
2017 Q2	$7.11M	Buy	88,384 +28,704	+48%	+$2.27M	0.27%	76
2017 Q1	$4.68M	Buy	59,680 +17,312	+41%	+$1.38M	0.19%	107
2016 Q4	$3.34M	Buy	+42,368	New	+$3.43M	0.15%	119

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuburgh Advisers's CVS Position: Q3 2019 in Review

Neuburgh Advisers reduced its CVS Health (CVS) stake by 9.8% in Q3 2019, selling an estimated $137K and leaving 21,392 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #279.

Neuburgh Advisers first reported a position in CVS in Q4 2016 and has held it in 12 quarters since. The position peaked at $10.1M in Q3 2017. 1,683 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

Neuburgh Advisers held 21,392 shares of CVS Health worth $1.35M as of Q3 2019.
Neuburgh Advisers sold 2,320 CVS Health shares in Q3 2019, an estimated $137K.
CVS Health made up 0.04% of Neuburgh Advisers's portfolio in Q3 2019, its #279 holding.
Neuburgh Advisers first reported a position in CVS Health in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's CVS Health position peaked at $10.1M in Q3 2017.
1,683 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.